CannaPharmaRX, Inc.
CPMD
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 183.51% | -30.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 183.51% | -30.93% | |||
| Cost of Revenue | 28.59% | 1.78% | |||
| Gross Profit | 29.17% | -23.60% | |||
| SG&A Expenses | 201.83% | -0.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.57% | 1.40% | |||
| Operating Income | -19.12% | -17.63% | |||
| Income Before Tax | -4.55% | -104.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.55% | -104.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.55% | -104.68% | |||
| EBIT | -19.12% | -17.63% | |||
| EBITDA | -- | -17.63% | |||
| EPS Basic | -4.76% | -110.00% | |||
| Normalized Basic EPS | -7.69% | -85.71% | |||
| EPS Diluted | -4.76% | -110.00% | |||
| Normalized Diluted EPS | -7.69% | -85.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||